Early intervention for infantile and childhood asthma

Expert Review of Clinical Immunology

Volumn 6, Issue 2, 2010, Pages 247-255

  Yoshihara, Shigemi ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Asthma; Asthma in children; Asthma in infants; Cysteinyl leukotriene receptor antagonist; Early intervention; Inhaled corticosteroid; Natural history; Prevention; Symptom burden; Th2 cytokine inhibitor

Indexed keywords

BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUTICASONE; KETOTIFEN FUMARATE; MONTELUKAST; NEDOCROMIL; PALIVIZUMAB; PLACEBO; PREDNISOLONE; SALBUTAMOL; SUPLATAST TOSYLATE; TERBUTALINE;

ASTHMA; BRONCHIOLITIS; DISEASE CONTROL; DISEASE COURSE; DISEASE EXACERBATION; DRUG DOSE REDUCTION; DRUG EFFECT; EARLY INTERVENTION; FORCED EXPIRATORY VOLUME; GROUPS BY AGE; HUMAN; LOW DRUG DOSE; LOWER RESPIRATORY TRACT INFECTION; PEAK EXPIRATORY FLOW; PEDIATRICIAN; POSITIVE END EXPIRATORY PRESSURE; PRESCRIPTION; PROGNOSIS; REVIEW; RISK REDUCTION; TREATMENT DURATION; TREATMENT RESPONSE; WHEEZING;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; AGE OF ONSET; ANTI-INFLAMMATORY AGENTS; ASTHMA; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; HEALTH PLANNING GUIDELINES; HUMANS; INCIDENCE; INFANT;

EID: 77949459965     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/eci.09.77     Document Type: Review

References (59)

1. Barnes PJ. Inhaled glucocorticoids for asthma. N. Engl. J. Med. 332(13), 868-875 (1995).
2. Barnes PJ. Efficacy of inhaled corticosteroids in asthma. J. Allergy Clin. Immunol. 102(4 Pt 1), 531-538 (1998).
3. Canonica GW. Treating asthma as an inflammatory disease. Chest 130(1 Suppl.), S21-S28 (2006).
4. Humbert M. The right tools at the right time. Chest 130(1 Suppl.), S29-S40 (2006).
5. Busse WW, Pedersen S, Pauwels RA et al. The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma. J. Allergy Clin. Immunol. 121(5), 1167-1174 (2008).
6. Silverman M, Pedersen S, Martinez F. Early intervention in childhood asthma. Eur. Respir. J. 12(1), 1-2 (1998).
7. Saglani S, Malmstrom K, Pelkonen AS et al. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am. J. Respir. Crit. Care Med. 171(7), 722-727 (2005).
8. Barbato A, Turato G, Baraldo S et al. Epithelial damage and angiogenesis in the airways of children with asthma. Am. J. Respir. Crit. Care Med. 174(9), 975-981 (2006).
9. Martinez FD, Wright AL, Taussig LM et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N. Engl. J. Med. 332(3), 133-138 (1995).
10. Martinez FD. Development of wheezing disorders and asthma in preschool children. Pediatrics 109(2 Suppl.), 362-367 (2002).
11. Haahtela T, Jarvinen M, Kava T et al. Comparison of a b2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N. Engl. J. Med. 325(6), 388-392 (1991).
12. Haahtela T, Jarvinen M, Kava T et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N. Engl. J. Med. 331(11), 700-705 (1994).
13. Selroos O, Pietinalho A, Lofroos AB et al. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 108(5), 1228-1234 (1995).
14. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir. Med. 88(5), 373-381 (1994).
15. Pauwels RA, Pedersen S, Busse WW et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 361(9363), 1071-1076 (2003).
16. Chen YZ, Busse WW, Pedersen S et al. Early intervention of recent onset mild persistent asthma in children aged under 11 yrs: the Steroid Treatment As Regular Therapy in early asthma (START) trial. Pediatr. Allergy Immunol. 17(Suppl. 17), 7-13 (2006).
17. Szefler S, Weiss S, Tonacia J. Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N. Engl. J. Med. 343(15), 1054-1063 (2000).
18. Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids. New developments. Am. J. Respir. Crit. Care Med. 157(3 Pt 2), S1-S53 (1998)
19. Nielsen KG, Bisgaard H. The effect of inhaled budesonide on symptoms, lung function, and cold air and methacholine responsiveness in 2-to 5-year-old asthmatic children. Am. J. Respir. Crit. Care Med. 162(4 Pt 1), 1500-1506 (2000).
20. Pao CS, McKenzie SA. Randomized controlled trial of fluticasone in preschool children with intermittent wheeze. Am. J. Respir. Crit. Care Med. 166(7), 945-949 (2002).
21. Teper AM, Kofman CD, Szulman GA et al. Fluticasone improves pulmonary function in children under 2 years old with risk factors for asthma. Am. J. Respir. Crit. Care Med. 171(6), 587-590 (2005).
22. Hofhuis W, van der Wiel EC, Nieuwhof EM et al. Efficacy of fluticasone propionate on lung function and symptoms in wheezy infants. Am. J. Respir. Crit. Care Med. 171(4), 328-333 (2005).
23. Pelkonen AS, Malmstrom K, Malmberg LP et al. Budesonide improves decreased airway conductance in infants with respiratory symptoms. Arch. Dis. Child. 94(7), 536-541 (2009).
24. Guilbert TW, Morgan WJ, Zeiger RS et al. Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma. J. Allergy Clin. Immunol. 114(6), 1282-1287 (2004).
25. Guilbert TW, Morgan WJ, Zeiger RS et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N. Engl. J. Med. 354(19), 1985-1997 (2006).
26. Bisgaard H, Hermansen MN, Loland L et al. Intermittent inhaled corticosteroids in infants with episodic wheezing. N. Engl. J. Med. 354(19), 1998-2005 (2006).
27. Murray CS, Woodcock A, Langley SJ et al. Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy Infants (IFWIN): double-blind, randomised, controlled study. Lancet 368(9537), 754-762 (2006).
28. Konig P, Shaffer J. The effect of drug therapy on long-term outcome of childhood asthma: a possible preview of the international guidelines. J. Allergy Clin. Immunol. 98(6 Pt 1), 1103-1111 (1996).
29. Yoshihara S, Kanno N, Yamada Y et al. Effects of early intervention with inhaled sodium cromoglycate in childhood asthma. Lung 184(2), 63-72 (2006).
30. Leflein JG, Szefler SJ, Murphy KR et al. Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial. Pediatrics 109(5), 866-872 (2002).
31. Furusho K, Nishikawa K, Sasaki S et al. The combination of nebulized sodium cromoglycate and salbutamol in the treatment of moderate-to-severe asthma in children. Pediatr. Allergy Immunol. 13(3), 209-216 (2002).
32. Bacharier LB, Boner A, Carlsen KH et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 63(1), 5-34 (2008).
33. Garcia Garcia ML, Wahn U, Gilles L et al. Montelukast, compared with fluticasone, for control of asthma among 6-to 14-year-old patients with mild asthma: the MOSAIC study. Pediatrics 116(2), 360-369 (2005).
34. Szefler SJ, Phillips BR, Martinez FD et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J. Allergy Clin. Immunol. 115(2), 233-242 (2005).
35. Zeiger RS, Szefler SJ, Phillips BR et al. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. J. Allergy Clin. Immunol. 117(1), 45-52 (2006).
36. Straub DA, Moeller A, Minocchieri S et al. The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma. Eur. Respir. J. 25(2), 289-294 (2005).
37. Knorr B, Franchi LM, Bisgaard H et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 108(3), e48 (2001).
38. Yoshihara S, Ono M, Yamada Y et al. Early intervention with suplatast tosilate for prophylaxis of pediatric atopic asthma: a pilot study. Pediatr. Allergy Immunol. 20(5), 486-492 (2009).
39. Martinez FD. Heterogeneity of the association between lower respiratory illness in infancy and subsequent asthma. Proc. Am. Thorac. Soc. 2(2), 157-161 (2005).
40. Gern JE, Rosenthal LA, Sorkness RL et al. Effects of viral respiratory infections on lung development and childhood asthma. J. Allergy Clin. Immunol. 115(4), 668-674 (2005).
41. Sigurs N, Gustafsson PM, Bjarnason R et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am. J. Respir. Crit. Care Med. 171(2), 137-141 (2005).
42. Bisgaard H. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am. J. Respir. Crit. Care Med. 167(3), 379-383 (2003).
43. Bisgaard H, Flores-Nunez A, Goh A et al. Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children. Am. J. Respir. Crit. Care Med. 178(8), 854-860 (2008).
44. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102(3), 531-537 (1998).
45. Pedraz C, Carbonell-Estrany X, Figueras-Aloy J et al. Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants. Pediatr. Infect. Dis. J. 22(9), 823-827 (2003).
46. Simoes EA, Groothuis JR, Carbonell-Estrany X et al. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. J. Pediatr. 151(1), 34-42 (2007).
47. Kusel MM, de Klerk NH, Kebadze T et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J. Allergy Clin. Immunol. 119(5), 1105-1110 (2007).
48. Lemanske RF Jr, Jackson DJ, Gangnon RE et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J. Allergy Clin. Immunol. 116(3), 571-577 (2005).
49. Kotaniemi-Syrjanen A, Vainionpaa R, Reijonen TM et al. Rhinovirus-induced wheezing in infancy -the first sign of childhood asthma? J. Allergy Clin. Immunol. 111(1), 66-71 (2003).
50. Lehtinen P, Ruohola A, Vanto T et al. Prednisolone reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or eczema. J. Allergy Clin. Immunol. 119(3), 570-575 (2007).
51. Castro-Rodriguez JA, Rodrigo GJ. Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis. Pediatrics 123(3), e519-e525 (2009).
52. Stern DA, Morgan WJ, Halonen M et al. Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study. Lancet 372(9643), 1058-1064 (2008).
53. Morgan WJ, Stern DA, Sherrill DL et al. Outcome of asthma and wheezing in the first 6 years of life: follow-up through adolescence. Am. J. Respir. Crit. Care Med. 172(10), 1253-1258 (2005).
54. Castro-Rodriguez JA, Holberg CJ, Wright AL et al. A clinical index to define risk of asthma in young children with recurrent wheezing. Am. J. Respir. Crit. Care Med. 162(4 Pt 1), 1403-1406 (2000).
55. Piippo-Savolainen E, Korppi M. Wheezy babies -wheezy adults? Review on long-term outcome until adulthood after early childhood wheezing. Acta Paediatr. 97(1), 5-11 (2008).
56. Payne DN, Rogers AV, Adelroth E et al. Early thickening of the reticular basement membrane in children with difficult asthma. Am. J. Respir. Crit. Care Med. 167(1), 78-82 (2003).
57. Barbato A, Turato G, Baraldo S et al. Airway inflammation in childhood asthma. Am. J. Respir. Crit. Care Med. 168(7), 798-803 (2003).
58. Saglani S, Payne DN, Zhu J et al. Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am. J. Respir. Crit. Care Med. 176(9), 858-864 (2007).
59. Sly PD, Boner AL, Bjorksten B et al. Early identification of atopy in the prediction of persistent asthma in children. Lancet 372(9643), 1100-1106 (2008).